Loading…
Anti‐MDA5‐associated dermatomyositis
Anti‐MDA5‐associated dermatomyositis (MDA5‐associated DM) is an uncommon presentation of idiopathic inflammatory myositis, typically amyopathic, associated with rapidly progressive, treatment refractory interstitial lung disease and poor prognosis, particularly in patients with concomitant rapidly p...
Saved in:
Published in: | Internal medicine journal 2020-04, Vol.50 (4), p.484-487 |
---|---|
Main Authors: | , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c3539-e1809c6b4d1232f33e6b2568aead6c3bd2b3fb81de1d4b912a602954f54b32993 |
---|---|
cites | cdi_FETCH-LOGICAL-c3539-e1809c6b4d1232f33e6b2568aead6c3bd2b3fb81de1d4b912a602954f54b32993 |
container_end_page | 487 |
container_issue | 4 |
container_start_page | 484 |
container_title | Internal medicine journal |
container_volume | 50 |
creator | Gupta, Rajiv Kumar, Sunil Gow, Peter (Hsien‐Cheng) Chang, Leon Yen, Linda |
description | Anti‐MDA5‐associated dermatomyositis (MDA5‐associated DM) is an uncommon presentation of idiopathic inflammatory myositis, typically amyopathic, associated with rapidly progressive, treatment refractory interstitial lung disease and poor prognosis, particularly in patients with concomitant rapidly progressive interstitial lung disease (RP‐ILD). We report two cases of MDA5‐associated DM with fatal outcome in one of the patients, despite ‘aggressive triple therapy’ for RP‐ILD. |
doi_str_mv | 10.1111/imj.14789 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2388003305</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2388003305</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3539-e1809c6b4d1232f33e6b2568aead6c3bd2b3fb81de1d4b912a602954f54b32993</originalsourceid><addsrcrecordid>eNp10L9OwzAQBnALgSgUBl4AIbGUIa3ts514rMq_olYsMFt27EiukqbEqVA3HoFn5Elwm8KAxC13w0-fTh9CFwQPSZyRrxZDwtJMHqATwhhPuJTscHezBEsMPXQawgJjkoJkx6gHlKZYUHKCBuNl678-Pue3Yx6XDqHOvW6dvbKuqXRbV5s6-NaHM3RU6DK48_3uo9f7u5fJYzJ7fphOxrMkBw4ycSTDMheGWUKBFgBOGMpFpp22IgdjqYHCZMQ6YpmRhGqBqeSs4MwAlRL6aNDlrpr6be1CqyofcleWeunqdVAUsgxjAMwjvf5DF_W6WcbvtiplqcyEiOqmU3lTh9C4Qq0aX-lmowhW2_pUrE_t6ov2cp-4NpWzv_KnrwhGHXj3pdv8n6Sm86cu8htl43iu</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2387479866</pqid></control><display><type>article</type><title>Anti‐MDA5‐associated dermatomyositis</title><source>Wiley-Blackwell Read & Publish Collection</source><creator>Gupta, Rajiv ; Kumar, Sunil ; Gow, Peter ; (Hsien‐Cheng) Chang, Leon ; Yen, Linda</creator><creatorcontrib>Gupta, Rajiv ; Kumar, Sunil ; Gow, Peter ; (Hsien‐Cheng) Chang, Leon ; Yen, Linda</creatorcontrib><description>Anti‐MDA5‐associated dermatomyositis (MDA5‐associated DM) is an uncommon presentation of idiopathic inflammatory myositis, typically amyopathic, associated with rapidly progressive, treatment refractory interstitial lung disease and poor prognosis, particularly in patients with concomitant rapidly progressive interstitial lung disease (RP‐ILD). We report two cases of MDA5‐associated DM with fatal outcome in one of the patients, despite ‘aggressive triple therapy’ for RP‐ILD.</description><identifier>ISSN: 1444-0903</identifier><identifier>EISSN: 1445-5994</identifier><identifier>DOI: 10.1111/imj.14789</identifier><identifier>PMID: 32270621</identifier><language>eng</language><publisher>Melbourne: John Wiley & Sons Australia, Ltd</publisher><subject>anti‐MDA5‐associated dermatomyositis ; Autoantibodies ; cyclosporine ; Dermatomyositis ; Dermatomyositis - complications ; Dermatomyositis - diagnosis ; Dermatomyositis - drug therapy ; Humans ; Inflammation ; inflammatory myopathy ; intravenous immunoglobulins ; Lung diseases ; Lung Diseases, Interstitial - diagnostic imaging ; Lung Diseases, Interstitial - etiology ; MDA5‐associated interstitial lung disease ; Myositis</subject><ispartof>Internal medicine journal, 2020-04, Vol.50 (4), p.484-487</ispartof><rights>2020 Royal Australasian College of Physicians</rights><rights>2020 Royal Australasian College of Physicians.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3539-e1809c6b4d1232f33e6b2568aead6c3bd2b3fb81de1d4b912a602954f54b32993</citedby><cites>FETCH-LOGICAL-c3539-e1809c6b4d1232f33e6b2568aead6c3bd2b3fb81de1d4b912a602954f54b32993</cites><orcidid>0000-0001-5908-4737</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32270621$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Gupta, Rajiv</creatorcontrib><creatorcontrib>Kumar, Sunil</creatorcontrib><creatorcontrib>Gow, Peter</creatorcontrib><creatorcontrib>(Hsien‐Cheng) Chang, Leon</creatorcontrib><creatorcontrib>Yen, Linda</creatorcontrib><title>Anti‐MDA5‐associated dermatomyositis</title><title>Internal medicine journal</title><addtitle>Intern Med J</addtitle><description>Anti‐MDA5‐associated dermatomyositis (MDA5‐associated DM) is an uncommon presentation of idiopathic inflammatory myositis, typically amyopathic, associated with rapidly progressive, treatment refractory interstitial lung disease and poor prognosis, particularly in patients with concomitant rapidly progressive interstitial lung disease (RP‐ILD). We report two cases of MDA5‐associated DM with fatal outcome in one of the patients, despite ‘aggressive triple therapy’ for RP‐ILD.</description><subject>anti‐MDA5‐associated dermatomyositis</subject><subject>Autoantibodies</subject><subject>cyclosporine</subject><subject>Dermatomyositis</subject><subject>Dermatomyositis - complications</subject><subject>Dermatomyositis - diagnosis</subject><subject>Dermatomyositis - drug therapy</subject><subject>Humans</subject><subject>Inflammation</subject><subject>inflammatory myopathy</subject><subject>intravenous immunoglobulins</subject><subject>Lung diseases</subject><subject>Lung Diseases, Interstitial - diagnostic imaging</subject><subject>Lung Diseases, Interstitial - etiology</subject><subject>MDA5‐associated interstitial lung disease</subject><subject>Myositis</subject><issn>1444-0903</issn><issn>1445-5994</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><recordid>eNp10L9OwzAQBnALgSgUBl4AIbGUIa3ts514rMq_olYsMFt27EiukqbEqVA3HoFn5Elwm8KAxC13w0-fTh9CFwQPSZyRrxZDwtJMHqATwhhPuJTscHezBEsMPXQawgJjkoJkx6gHlKZYUHKCBuNl678-Pue3Yx6XDqHOvW6dvbKuqXRbV5s6-NaHM3RU6DK48_3uo9f7u5fJYzJ7fphOxrMkBw4ycSTDMheGWUKBFgBOGMpFpp22IgdjqYHCZMQ6YpmRhGqBqeSs4MwAlRL6aNDlrpr6be1CqyofcleWeunqdVAUsgxjAMwjvf5DF_W6WcbvtiplqcyEiOqmU3lTh9C4Qq0aX-lmowhW2_pUrE_t6ov2cp-4NpWzv_KnrwhGHXj3pdv8n6Sm86cu8htl43iu</recordid><startdate>202004</startdate><enddate>202004</enddate><creator>Gupta, Rajiv</creator><creator>Kumar, Sunil</creator><creator>Gow, Peter</creator><creator>(Hsien‐Cheng) Chang, Leon</creator><creator>Yen, Linda</creator><general>John Wiley & Sons Australia, Ltd</general><general>Wiley Subscription Services, Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>7U9</scope><scope>H94</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0001-5908-4737</orcidid></search><sort><creationdate>202004</creationdate><title>Anti‐MDA5‐associated dermatomyositis</title><author>Gupta, Rajiv ; Kumar, Sunil ; Gow, Peter ; (Hsien‐Cheng) Chang, Leon ; Yen, Linda</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3539-e1809c6b4d1232f33e6b2568aead6c3bd2b3fb81de1d4b912a602954f54b32993</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>anti‐MDA5‐associated dermatomyositis</topic><topic>Autoantibodies</topic><topic>cyclosporine</topic><topic>Dermatomyositis</topic><topic>Dermatomyositis - complications</topic><topic>Dermatomyositis - diagnosis</topic><topic>Dermatomyositis - drug therapy</topic><topic>Humans</topic><topic>Inflammation</topic><topic>inflammatory myopathy</topic><topic>intravenous immunoglobulins</topic><topic>Lung diseases</topic><topic>Lung Diseases, Interstitial - diagnostic imaging</topic><topic>Lung Diseases, Interstitial - etiology</topic><topic>MDA5‐associated interstitial lung disease</topic><topic>Myositis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Gupta, Rajiv</creatorcontrib><creatorcontrib>Kumar, Sunil</creatorcontrib><creatorcontrib>Gow, Peter</creatorcontrib><creatorcontrib>(Hsien‐Cheng) Chang, Leon</creatorcontrib><creatorcontrib>Yen, Linda</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Internal medicine journal</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Gupta, Rajiv</au><au>Kumar, Sunil</au><au>Gow, Peter</au><au>(Hsien‐Cheng) Chang, Leon</au><au>Yen, Linda</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Anti‐MDA5‐associated dermatomyositis</atitle><jtitle>Internal medicine journal</jtitle><addtitle>Intern Med J</addtitle><date>2020-04</date><risdate>2020</risdate><volume>50</volume><issue>4</issue><spage>484</spage><epage>487</epage><pages>484-487</pages><issn>1444-0903</issn><eissn>1445-5994</eissn><abstract>Anti‐MDA5‐associated dermatomyositis (MDA5‐associated DM) is an uncommon presentation of idiopathic inflammatory myositis, typically amyopathic, associated with rapidly progressive, treatment refractory interstitial lung disease and poor prognosis, particularly in patients with concomitant rapidly progressive interstitial lung disease (RP‐ILD). We report two cases of MDA5‐associated DM with fatal outcome in one of the patients, despite ‘aggressive triple therapy’ for RP‐ILD.</abstract><cop>Melbourne</cop><pub>John Wiley & Sons Australia, Ltd</pub><pmid>32270621</pmid><doi>10.1111/imj.14789</doi><tpages>4</tpages><orcidid>https://orcid.org/0000-0001-5908-4737</orcidid></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1444-0903 |
ispartof | Internal medicine journal, 2020-04, Vol.50 (4), p.484-487 |
issn | 1444-0903 1445-5994 |
language | eng |
recordid | cdi_proquest_miscellaneous_2388003305 |
source | Wiley-Blackwell Read & Publish Collection |
subjects | anti‐MDA5‐associated dermatomyositis Autoantibodies cyclosporine Dermatomyositis Dermatomyositis - complications Dermatomyositis - diagnosis Dermatomyositis - drug therapy Humans Inflammation inflammatory myopathy intravenous immunoglobulins Lung diseases Lung Diseases, Interstitial - diagnostic imaging Lung Diseases, Interstitial - etiology MDA5‐associated interstitial lung disease Myositis |
title | Anti‐MDA5‐associated dermatomyositis |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T03%3A52%3A50IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Anti%E2%80%90MDA5%E2%80%90associated%20dermatomyositis&rft.jtitle=Internal%20medicine%20journal&rft.au=Gupta,%20Rajiv&rft.date=2020-04&rft.volume=50&rft.issue=4&rft.spage=484&rft.epage=487&rft.pages=484-487&rft.issn=1444-0903&rft.eissn=1445-5994&rft_id=info:doi/10.1111/imj.14789&rft_dat=%3Cproquest_cross%3E2388003305%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c3539-e1809c6b4d1232f33e6b2568aead6c3bd2b3fb81de1d4b912a602954f54b32993%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2387479866&rft_id=info:pmid/32270621&rfr_iscdi=true |